CD133 (prominin-1), a 5-transmembrane glycoprotein [13] that is a putative marker for cancer stem cells (CSCs) in solid tumors including ovarian cancer, has been thought to define a subpopulation of tumor-initiating cells with enhanced resistance to platinum [14–16]. Here, PROM1 is linked to neoplasm.